EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study

Noam Sugar, Hilla Chen iD, Gilad Segev iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Noam Sugar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel. Hauptthemen laut MEDLINE: Cat Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary glomerular disease resulting in protein-losing nephropathy (PLN) is an uncommon cause of chronic kidney disease in cats, yet is important to recognize because it warrants specific treatment that impacts outcome. Hypothesis/Objective Characterize clinicopathologic findings, prognostic indicators, and short- (≤30 days) and long-term survival of cats with PLN. Animals Thirty-seven cats with naturally occurring PLN.

Methods

Medical records of cats with PLN admitted to a veterinary teaching hospital were retrospectively reviewed.

Results

Median age was 3 years (range, 1.5-11.5 years) and 17/37 (46%) were males. Short-term survival was 57%. The estimated median survival time of all cats was 424 days (95% confidence interval [CI], 0-1098 days). Common clinical signs included lethargy (57%), edema (46%) and weight loss (35%). Edema was more common in short-term survivors compared with nonsurvivors (odds ratio [OR], 0.21; 95% CI, 0.05-0.86-20.4; P = .04). Serum creatinine concentration at presentation was negatively associated with long-term survival (OR, 1.3; 95% CI, 1.03-1.52; P = .01). Administration of immunosuppressive and antiproteinuric medications was more common among short-term survivors compared with nonsurvivors (18/20 [90%] vs 9/16 [56%]; OR, 7.0; 95% CI, 1.2-40.8; P = .05 and 17/20 [85%] vs 7/16 [44%]; OR, 7.3; 95% CI, 1.5-35.2; P = .01, respectively). Partial or complete remission was documented in 11/31 (36%) cats and was associated with both short (OR, 3.3; 95% CI, 1.7-6.5; P < .001) and long-term survival (P = .003). Conclusion and Clinical Importance Cats with PLN have a guarded prognosis, but achieving remission improves outcome. Cats presented with edema rather than azotemia are more likely to respond to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesCatsAnimalsRetrospective StudiesMaleFemalePrognosisCreatinineEdema

Stichwörter der Autor:innen

chronic kidney diseaseglomerular diseaseproteinuria

Substanzen

Creatinine

Autor:innen und Institutionen

  • Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.

ORCID-Profile: Hilla Chen, Gilad Segev

Zitieren

APA

Sugar, N., Chen, H., & Segev, G. (2024). Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17240

Vancouver

Sugar N, Chen H, Segev G. Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17240

BibTeX
@article{Sugar2024,
  author = {Sugar, Noam and Chen, Hilla and Segev, Gilad},
  title = {Clinical findings, prognostic factors, and outcome of protein-losing nephropathy in cats: A retrospective study},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17240}
}
Kostenlos starten →